Arbeitspapier
Determinants of pharmaceutical innovation: The role of technological opportunities revisited
Recent empirical contributions emphasize the importance of (potential) market size for the development of new pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry's R&D activities. Against this background I analyze the relationship between (potential) market size, technological opportunities, and the number of new pharmaceuticals in the United States. Technological opportunities are operationalized as growth rates of the relevant knowledge stock as proposed by Andersen (1999, 1998). I analyze a unique dataset by using an entry stock Poisson quasi-maximum likelihood estimator. The results reveal a rather robust and significantly positive response of the number of new pharmaceuticals, i.e., new molecular entities or new drug approvals, to market size and technological opportunities.
- Sprache
-
Englisch
- Erschienen in
-
Series: Jena Economic Research Papers ; No. 2012,018
- Klassifikation
-
Wirtschaft
Innovation and Invention: Processes and Incentives
Demographic Economics: General
Demand and Supply of Labor: General
- Thema
-
Determinants of Innovation
Pharmaceuticals
Demand
Technological Opportunities
Pharmazeutische Forschung
Produktinnovation
Arzneimittelmarkt
Technischer Fortschritt
USA
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Rake, Bastian
- Ereignis
-
Veröffentlichung
- (wer)
-
Friedrich Schiller University Jena and Max Planck Institute of Economics
- (wo)
-
Jena
- (wann)
-
2012
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:43 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Rake, Bastian
- Friedrich Schiller University Jena and Max Planck Institute of Economics
Entstanden
- 2012